Article

Mary Bohn on the Landscape of Multiple Myeloma Treatment

Author(s):

Mary Bohn

Mary Bohn, RN, OCN, a nurse at Froedtert Hospital in Milwaukee, Wisconsin, discusses the landscape and side effects of treatment for patients with multiple myeloma.

Mary Bohn, RN, OCN, a nurse at Froedtert Hospital in Milwaukee, Wisconsin, discusses the landscape and side effects of treatment for patients with multiple myeloma. Bohn was one of our 2016 Multiple Myeloma Heroes.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Photo of Dr. Rosario Ligresti
Image of women with text.
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.
Related Content
Multiple myeloma is a chronic blood cancer affecting plasma cells, but with today’s treatments many patients can manage symptoms and live fulfilling lives.
August 24th 2025

What Does Multiple Myeloma Mean?

Gina Mauro
Top Headlines on CAR-T Cell Therapy
August 24th 2025

Top Headlines on CAR-T Cell Therapy

Alex Biese Brielle Benyon
The FDA declined approval of Darzalex Faspro for newly diagnosed, transplant-ineligible multiple myeloma in its current form: © stock.adobe.com.
August 24th 2025

FDA Gives Complete Response Letter for Darzalex Faspro Quadruplet Regimen

Spencer Feldman
Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic
August 24th 2025

Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic

Jamie Cesanek
SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status: © stock.adobe.com.
August 24th 2025

FDA Grants Orphan Drug Status to SAR446523 for Relapsed Myeloma

Spencer Feldman
Image of FDA sign.
August 24th 2025

FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma

Ryan Scott